Your browser doesn't support javascript.
loading
Dual-responsive nanovaccine for cytosolic delivery of antigens to boost cellular immune responses and cancer immunotherapy.
Sui, Yang; Li, Ji; Qu, Jiqiang; Fang, Ting; Zhang, Hongyan; Zhang, Jian; Wang, Zheran; Xia, Mingyu; Dai, Yinghui; Wang, Dongkai.
Afiliação
  • Sui Y; Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Li J; Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Qu J; School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Fang T; School of Pharmacy, China Medical University, Shenyang 110122, China.
  • Zhang H; School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Zhang J; Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Wang Z; Department of Mathematics and Statistics, Auburn University, Auburn, AL 36849, USA.
  • Xia M; School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Dai Y; Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Wang D; Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
Asian J Pharm Sci ; 17(4): 583-595, 2022 Jul.
Article em En | MEDLINE | ID: mdl-36101894

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article